Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
More than 70 million people worldwide are infected with hepatitis C virus, a major cause of liver cirrhosis, liver failure and hepatocellular carcinoma world-wide. In the last decade, this cancer has emerged as the second leading cause of cancer death and the global burden is increasing by two milli...
保存先:
第一著者: | Thomas F. Baumert (auth) |
---|---|
その他の著者: | Steven K.H. Foung (auth) |
フォーマット: | 電子媒体 図書の章 |
言語: | 英語 |
出版事項: |
Frontiers Media SA
2019
|
シリーズ: | Frontiers Research Topics
|
主題: | |
オンライン・アクセス: | DOAB: download the publication DOAB: description of the publication |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Influenza Virus Vaccines and Immunotherapies
著者:: Arun Kumar
出版事項: (2016) -
Vaccines against RNA Viruses
出版事項: (2020) -
Virus-Like Particle Vaccines
出版事項: (2020) -
Influenza Virus and Vaccination
著者:: Nogales, Aitor
出版事項: (2020) -
Immune responses to AAV vectors, from bench to bedside
著者:: Hildegard Buning
出版事項: (2015)